Effect of Sex on the Oncological Outcomes in Response to Immunotherapy and Antibody-drug Conjugates in Patients with Urothelial and Kidney Cancer: A Systematic …
Background and objective Immune checkpoint inhibitors (ICIs) and antibody-drug
conjugates (ADCs) herald a transformative era in metastatic renal cell carcinoma (RCC) and …
conjugates (ADCs) herald a transformative era in metastatic renal cell carcinoma (RCC) and …
Effect of Sex on the Oncological Outcomes in Response to Immunotherapy and Antibody-drug Conjugates in Patients with Urothelial and Kidney Cancer: A Systematic …
C Cerrato, F Crocerossa, M Marchioni… - European Urology …, 2024 - europepmc.org
Methods A systematic search was conducted up to October 2023 for English articles on ICIs
and ADCs as systemic therapies (ICIs in first-line and adjuvant treatment for RCC, ICIs and …
and ADCs as systemic therapies (ICIs in first-line and adjuvant treatment for RCC, ICIs and …
Effect of Sex on the Oncological Outcomes in Response to Immunotherapy and Antibody-drug Conjugates in Patients with Urothelial and Kidney Cancer: A Systematic …
C Cerrato, F Crocerossa, M Marchioni… - European urology … - pubmed.ncbi.nlm.nih.gov
Background and objective Immune checkpoint inhibitors (ICIs) and antibody-drug
conjugates (ADCs) herald a transformative era in metastatic renal cell carcinoma (RCC) and …
conjugates (ADCs) herald a transformative era in metastatic renal cell carcinoma (RCC) and …
Effect of Sex on the Oncological Outcomes in Response to Immunotherapy and Antibody-drug Conjugates in Patients with Urothelial and Kidney Cancer: A Systematic …
C Cerrato, F Crocerossa… - European Urology … - euoncology.europeanurology.com
Background and objective Immune checkpoint inhibitors (ICIs) and antibody-drug
conjugates (ADCs) herald a transformative era in metastatic renal cell carcinoma (RCC) and …
conjugates (ADCs) herald a transformative era in metastatic renal cell carcinoma (RCC) and …